Skip to main content
Walid Haddad, MD, Cardiology, Shawnee, OK

Walid John Haddad MD

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology


Physician

Join to View Full Profile
  • 3306 N Kickapoo AveSte 150Shawnee, OK 74804

  • Phone+1 405-628-6535

  • Fax+1 405-972-7587

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 2 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Walid Haddad, MD is a cardiologist in Shawnee, Oklahoma. He is currently licensed to practice medicine in Oklahoma, Florida, and West Virginia.

Education & Training

  • West Virginia University
    West Virginia UniversityFellowship, Cardiovascular Disease, 1995 - 1996
  • West Virginia University
    West Virginia UniversityResidency, Internal Medicine, 1991 - 1994
  • West Virginia University School of Medicine
    West Virginia University School of MedicineClass of 1991

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 1998 - 2027
  • FL State Medical License
    FL State Medical License 1997 - 2000
  • WV State Medical License
    WV State Medical License 1993 - 2000
  • Cardiovascular Disease
    National Board of Physicians and Surgeons Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015, 2017
  • CMS Meaningful Use Stage 1 Certification Centricity Practice Solution, GE Healthcare, 2015, 2017
  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2015, 2017

Press Mentions

  • Rapid Medical™ Reports No Safety Concerns for Medium Vessel Occlusions in the Interim Safety Analysis of the DISTALS Study with TIGERTRIEVER™13
    Rapid Medical™ Reports No Safety Concerns for Medium Vessel Occlusions in the Interim Safety Analysis of the DISTALS Study with TIGERTRIEVER™13September 4th, 2024
  • Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trial–Offering Treatment to New Ischemic Stroke Patient Population
    Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trial–Offering Treatment to New Ischemic Stroke Patient PopulationJune 2nd, 2022
  • TIGER Trial Demonstrates High Safety and Efficacy for World’s First Adjustable Thrombectomy Device
    TIGER Trial Demonstrates High Safety and Efficacy for World’s First Adjustable Thrombectomy DeviceMarch 24th, 2021